Knights of Columbus Asset Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,034
Closed -$263K 416
2026
Q1
$263K Buy
3,034
+912
+43% +$87.4K 0.01% 338
2025
Q4
$204K Sell
2,122
-1,617
-43% -$157K 0.01% 345
2025
Q3
$356K Buy
3,739
+1,629
+77% +$150K 0.02% 303
2025
Q2
$184K Hold
2,110
0.01% 311
2025
Q1
$190K Buy
2,110
+44
+2% +$3.94K 0.01% 298
2024
Q4
$165K Sell
2,066
-2,346
-53% -$203K 0.01% 310
2024
Q3
$397K Sell
4,412
-60
-1% -$5.05K 0.03% 280
2024
Q2
$352K Hold
4,472
0.02% 315
2024
Q1
$390K Buy
4,472
+2,428
+119% +$207K 0.03% 288
2023
Q4
$168K Buy
2,044
+44
+2% +$3.35K 0.01% 325
2023
Q3
$157K Sell
2,000
-6,034
-75% -$505K 0.01% 326
2023
Q2
$708K Buy
8,034
+5,706
+245% +$491K 0.06% 262
2023
Q1
$188K Hold
2,328
0.02% 302
2022
Q4
$181K Sell
2,328
-79
-3% -$6.4K 0.02% 297
2022
Q3
$194K Hold
2,407
0.02% 279
2022
Q2
$216K Buy
+2,407
New +$244K 0.02% 272
2020
Q2
Sell
-60,425
Closed -$5.45M 380
2020
Q1
$5.45M Hold
60,425
0.69% 26
2019
Q4
$6.86M Sell
60,425
-2,000
-3% -$219K 0.61% 27
2019
Q3
$6.78M Buy
62,425
+850
+1% +$88.7K 2.58% 4
2019
Q2
$6M Buy
61,575
+2,400
+4% +$219K 2.36% 4
2019
Q1
$5.39M Buy
59,175
+300
+0.5% +$26.9K 2.17% 6
2018
Q4
$5.36M Sell
58,875
-2,400
-4% -$224K 2.45% 4
2018
Q3
$6.03M Buy
61,275
+675
+1% +$62.4K 2.43% 4
2018
Q2
$5.19M Buy
60,600
+500
+0.8% +$41.8K 2.52% 6
2018
Q1
$4.82M Buy
60,100
+16,600
+38% +$1.37M 2.2% 9
2017
Q4
$3.51M Buy
43,500
+300
+0.7% +$24K 2.27% 8
2017
Q3
$3.36M Buy
43,200
+3,150
+8% +$262K 2.27% 7
2017
Q2
$3.55M Sell
40,050
-150
-0.4% -$12.6K 2.46% 6
2017
Q1
$3.24M Buy
+40,200
New +$3.14M 2.29% 6

Other funds holding MDT

Knights of Columbus Asset Advisors's MDT Position: Q2 2026 in Review

Knights of Columbus Asset Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,034 shares — an estimated $263K sold.

Knights of Columbus Asset Advisors first reported a position in MDT in Q1 2017 and held it in 29 quarters. The position peaked at $6.86M in Q4 2019. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Knights of Columbus Asset Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 3,034 Medtronic shares in Q2 2026, an estimated $263K.
  • Knights of Columbus Asset Advisors first reported a position in Medtronic in Q1 2017 and held it in 29 quarters.
  • Knights of Columbus Asset Advisors's Medtronic position peaked at $6.86M in Q4 2019.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.